Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

DSIP research

6 articles to explore, with links to 7 original sources.

About DSIP

DSIP is a nine-residue peptide used in laboratory investigations of neuroendocrine signaling.

Explore study findings

  • Why Researchers Named DSIP After a Brain Wave

    DSIP, short for delta sleep-inducing peptide, is a nine-amino-acid chain also called emideltide. Its name reflects a result in an early animal experiment. Delta refers to slow electrical waves that can be measured with an electroencephalogram, or EEG.

    2 sources (1978, 2026)

  • What a Controlled DSIP Insomnia Study Found

    DSIP, or emideltide, is a nine-amino-acid peptide studied in sleep research. The question here is whether it improved chronic insomnia, a condition involving trouble sleeping together with consequences during the day. The 2026 FDA appraisal found that the human evidence remains inconclusive.

    2 sources (1992, 2026)

  • Why DSIP Behaved Differently During Anesthesia

    DSIP, also known as emideltide, attracted attention because of early findings about slow brain waves. A small anesthesia experiment asked whether the same molecule would deepen an already induced state of unconsciousness.

    1 source (2009)

Interpret the evidence

  • What a Small DSIP Study in Healthy Volunteers Can Tell Us

    Delta sleep-inducing peptide, called DSIP or emideltide, was tested in an early human study that asked how sleep changed in healthy volunteers. No recent controlled study addressing that same healthy-volunteer question was identified, so the original report is the direct source.

    2 sources (1981, 2026)

  • Why the DSIP Withdrawal Reports Cannot Establish a Treatment Effect

    Peptides are short chains of amino acids linked by peptide bonds. Researchers sometimes test whether a chain influences several signals at once, but a change in symptoms can have more than one cause.

    3 sources (1984–2026)

  • Why DSIP Free Form and Acetate Need Separate Evidence Checks

    Delta sleep-inducing peptide, or DSIP, illustrates why both levels of description are useful. The FDA's July 2026 briefing considered emideltide in its free form and emideltide acetate as distinct bulk substances.

    1 source (2026)

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.